Financing ·
bioAffinity Technologies, Inc. closed a private placement on August 14, 2026, raising approximately $3.6 million in…
BIAFWbioAffinity Technologies, Inc.
bioAffinity Technologies, Inc. closed a private placement on August 14, 2026, raising approximately $3.6 million in net proceeds after deducting fees and expenses. The company sold 8,462,027 pre-funded warrants at $0.4657 each, accompanied by Series A and Series B warrants to purchase up to 16,924,054 shares total. Each warrant carries an initial exercise price of $0.4727 per share and expires five years after issuance. The placement agent received a 7.5% cash fee plus warrants for 253,861 shares. Proceeds will fund working capital and general corporate purposes. bioAffinity Technologies operates in the biotechnology industry, focusing on noninvasive diagnostics and early cancer detection.